View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects With Previously Treated NTRK Fusion Cancers
  • Protocol ID
    LOXO-EXT-17005
  • Disease
    Disease Type Disease Subtype
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Sydney Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 1/2
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    11/07/2018
  • Study close date
    N/A
  • Study chair
  • Sponsor
    Loxo Oncology
Back to search results